Header Logo

Vu Hoang Tran

Concepts (121)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
5
2018
252
1.900
 Why?
Myocardial Infarction
5
2022
918
1.340
 Why?
Anxiety Disorders
2
2018
200
1.000
 Why?
Tachycardia, Ventricular
2
2018
131
0.990
 Why?
Patient Discharge
2
2018
518
0.840
 Why?
ST Elevation Myocardial Infarction
3
2022
95
0.800
 Why?
Non-ST Elevated Myocardial Infarction
2
2018
33
0.710
 Why?
Circulating Tumor DNA
4
2025
10
0.680
 Why?
Nutrition Surveys
2
2017
147
0.610
 Why?
Percutaneous Coronary Intervention
1
2022
223
0.580
 Why?
Early Detection of Cancer
4
2025
325
0.550
 Why?
Hyperglycemia
1
2018
104
0.540
 Why?
Ventricular Fibrillation
1
2018
107
0.530
 Why?
Deficiency Diseases
1
2017
13
0.520
 Why?
Iodine
1
2017
20
0.520
 Why?
Arrhythmias, Cardiac
1
2018
161
0.520
 Why?
Patient Admission
1
2018
197
0.500
 Why?
Cardiovascular Agents
1
2017
106
0.490
 Why?
Drug Utilization
1
2017
204
0.480
 Why?
Depressive Disorder
1
2018
284
0.480
 Why?
Hospital Mortality
2
2022
874
0.450
 Why?
Length of Stay
1
2017
826
0.410
 Why?
Aged
13
2025
14872
0.400
 Why?
Coronary Artery Disease
1
2017
322
0.400
 Why?
Middle Aged
12
2025
18169
0.390
 Why?
Healthcare Disparities
1
2017
408
0.370
 Why?
Risk Factors
7
2018
5407
0.370
 Why?
Female
16
2025
33857
0.350
 Why?
Male
14
2025
30898
0.350
 Why?
Incidence
4
2018
1413
0.350
 Why?
Biomarkers, Tumor
5
2025
522
0.330
 Why?
Prognosis
4
2018
1775
0.320
 Why?
Massachusetts
5
2018
2143
0.320
 Why?
Atrial Fibrillation
2
2018
869
0.320
 Why?
Humans
23
2025
64913
0.290
 Why?
Cell-Free Nucleic Acids
2
2025
14
0.280
 Why?
Prospective Studies
5
2025
3303
0.250
 Why?
Time Factors
3
2018
3757
0.250
 Why?
DNA Methylation
2
2025
301
0.240
 Why?
Neoplasms
3
2025
1362
0.230
 Why?
Logistic Models
2
2018
1269
0.210
 Why?
Aged, 80 and over
3
2018
5576
0.210
 Why?
Patient Readmission
2
2018
445
0.200
 Why?
Liver Neoplasms
2
2023
309
0.200
 Why?
Pseudomonas Infections
1
2023
74
0.200
 Why?
Prevalence
2
2017
1437
0.190
 Why?
Biomarkers
2
2018
1472
0.180
 Why?
Exome
1
2021
69
0.170
 Why?
Carcinoma, Hepatocellular
1
2023
176
0.170
 Why?
Risk Assessment
2
2018
2092
0.170
 Why?
Pneumonia
1
2023
291
0.170
 Why?
Gene Frequency
1
2020
122
0.160
 Why?
Coronary Artery Bypass
1
2022
292
0.160
 Why?
United States
3
2018
8067
0.160
 Why?
Cardiac Catheterization
1
2022
292
0.160
 Why?
Cardiovascular Diseases
2
2018
862
0.160
 Why?
Genetic Testing
1
2020
141
0.150
 Why?
Alleles
1
2020
453
0.150
 Why?
Mutation
2
2025
2659
0.150
 Why?
Theranostic Nanomedicine
1
2018
9
0.140
 Why?
Radiation-Sensitizing Agents
1
2018
16
0.140
 Why?
Odds Ratio
2
2018
755
0.140
 Why?
Genotype
1
2020
673
0.140
 Why?
Leukocyte Count
1
2018
101
0.140
 Why?
Vietnam
3
2025
182
0.140
 Why?
Gadolinium
1
2018
110
0.130
 Why?
Hospitalization
2
2022
1386
0.130
 Why?
Mortality
1
2018
160
0.130
 Why?
Protective Factors
1
2017
33
0.130
 Why?
Herpes Zoster
1
2017
22
0.130
 Why?
Cerebrovascular Disorders
1
2017
83
0.120
 Why?
Chi-Square Distribution
1
2017
414
0.120
 Why?
Breast Neoplasms
1
2025
1216
0.120
 Why?
Linear Models
1
2017
406
0.120
 Why?
Cohort Studies
2
2021
2609
0.120
 Why?
Blood Glucose
1
2018
497
0.120
 Why?
Survival Rate
1
2018
847
0.120
 Why?
Medication Adherence
1
2017
198
0.120
 Why?
Drug Monitoring
1
2017
202
0.120
 Why?
Follow-Up Studies
2
2018
2483
0.120
 Why?
Multivariate Analysis
1
2017
929
0.110
 Why?
Stroke
3
2018
1207
0.100
 Why?
Disease Progression
1
2018
1213
0.100
 Why?
Anticoagulants
1
2018
522
0.100
 Why?
Adult
5
2025
17284
0.100
 Why?
Registries
1
2017
903
0.100
 Why?
Health Services Accessibility
1
2018
588
0.100
 Why?
Nanoparticles
1
2018
544
0.090
 Why?
Depression
1
2018
892
0.090
 Why?
Quality of Life
1
2018
1256
0.080
 Why?
Treatment Outcome
2
2018
5774
0.080
 Why?
Retrospective Studies
2
2025
6831
0.080
 Why?
Cross-Sectional Studies
1
2017
2697
0.080
 Why?
Tobramycin
1
2023
6
0.050
 Why?
DNA, Neoplasm
1
2023
60
0.050
 Why?
Rabbits
1
2023
338
0.050
 Why?
Microbial Sensitivity Tests
1
2023
208
0.050
 Why?
Pseudomonas aeruginosa
1
2023
133
0.050
 Why?
Shock, Cardiogenic
1
2022
108
0.040
 Why?
Hospitals
1
2022
385
0.040
 Why?
Genome-Wide Association Study
1
2020
361
0.040
 Why?
Publication Bias
1
2018
21
0.040
 Why?
Georgia
1
2018
88
0.040
 Why?
Sex Distribution
1
2018
251
0.030
 Why?
Age Distribution
1
2018
260
0.030
 Why?
Polymorphism, Single Nucleotide
1
2020
510
0.030
 Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.030
 Why?
Forecasting
1
2018
230
0.030
 Why?
Anti-Bacterial Agents
1
2023
803
0.030
 Why?
Head and Neck Neoplasms
1
2018
165
0.030
 Why?
Administration, Oral
1
2018
371
0.030
 Why?
Phenotype
1
2020
1232
0.030
 Why?
Venous Thromboembolism
1
2018
148
0.030
 Why?
Comorbidity
1
2018
1115
0.030
 Why?
Brain Neoplasms
1
2018
318
0.030
 Why?
Melanoma
1
2018
332
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
799
0.030
 Why?
Pregnancy
1
2020
2366
0.020
 Why?
Animals
2
2023
21340
0.020
 Why?
Surveys and Questionnaires
1
2018
2759
0.020
 Why?
Mice
1
2018
11113
0.010
 Why?
Tran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (121)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_